Clinical Trial Update: The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/Phase 2 clinical trial at Siriraj Hospital is evaluating modified autologous cytokine-induced killer (CIK) cell immunotherapy for cholangioca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Neuroblastoma

Drugs mentioned

• Modified autologous cytokine-induced killer (CIK) cell therapy (cytokine-induced killer cells)

Snippet

Sponsor: Siriraj Hospital | Conditions: Cholangiocarcinoma, Neuroblastoma | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION